TABLE 1.

Demographics

CharacteristicValue for group
50-59 yr of age (n = 389)≥60 yr of age (n = 731)
No. (%) of subjects under protocol:
    010
        Refrigerated formulation66 (17.0)116 (15.9)
        Frozen formulation69 (17.7)116 (15.9)
    011
        Concomitant vaccination129 (33.2)253 (34.6)
        Sequential vaccination125 (32.1)246 (33.7)
No. (%) of subjects of gender:
    Male163 (41.9)334 (45.7)
    Female226 (58.1)397 (54.3)
Age (yr)
    Mean (SD)54.6 (2.8)68.1 (6.2)
    Median5467
    Rangea47-5960-97
No. (%) of patients of race:
    Caucasian245 (63.0)591 (71.0)
    African American91 (23.4)147 (20.1)
    Hispanic43 (11.1)41 (5.6)
    Asian3 (0.8)18 (2.5)
    Otherb7 (1.8)6 (0.8)
  • a One subject was 47 years old and was included in the group comprised of subjects 50 to 59 years of age.

  • b Native American, Indian, African, Asiatic, or multiracial.